In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.
This paper reports the results of an investigation into the blood response of polymers in vitro, using non-anticoagulated and heparinised blood and plasma. The materials studied were regenerated cellulose, (Cuprophan), an acrylonitrile-allyl sulphonate copolymer (AN69S), and medical grade polyvinyl chloride plasticised with di-2-ethyl-hexyl-phthalate (PVC/DEHP). Blood-material or plasma-material contact was achieved using a parallel plate flow cell, and C3a generation and FXII-like activity measured. The results of the study with non-anticoagulated human blood show that PVC/DEHP is a high complement activator. C3a concentration in the blood was higher after contact with PVC/DEHP than after contact with regenerated cellulose. The introduction of heparin in the blood induced complex alterations in the blood response. C3a generation could be elevated, decreased, or remain the same, depending on the material. The FXII-like activity on the surface of the PVC/DEHP after contact with plasma was also higher than the other two polymers. The introduction of heparin could increase or decrease FXII-like activity, depending on material. The patterns of response obtained with non-anticoagulated blood in vitro for AN69S and Cuprophan bore a strong resemblance with patterns of response obtained in the clinic, whereas those obtained with heparinised blood in vitro did not.
Lamba
N M
NM
Bioengineering Unit, University of Strathclyde, Glasgow, UK.
Courtney
J M
JM
Gaylor
J D
JD
Lowe
G D
GD
D000180:Acrylic Resins; D000181:Acrylonitrile / Q000031:analogs & derivatives; D000925:Anticoagulants / Q000097:blood* / Q000494:pharmacology*; D000990:Antithrombin III / Q000502:physiology; D001672:Biocompatible Materials; D001777:Blood Coagulation / Q000187:drug effects; D002482:Cellulose / Q000031:analogs & derivatives; D003167:Complement Activation / Q000187:drug effects; D015926:Complement C3a / Q000096:biosynthesis / Q000378:metabolism; D004051:Diethylhexyl Phthalate; D005174:Factor XII / Q000502:physiology; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006493:Heparin / Q000097:blood* / Q000494:pharmacology*; D006801:Humans; D010968:Plasticizers; D011143:Polyvinyl Chloride
D000180:Acrylic Resins; D000925:Anticoagulants; D001672:Biocompatible Materials; D005343:Fibrinolytic Agents; D010968:Plasticizers; C016892:AN-69; D015926:Complement C3a; D000990:Antithrombin III; D005174:Factor XII; D011143:Polyvinyl Chloride; D002482:Cellulose; D006493:Heparin; C009865:cuprammonium cellulose; D004051:Diethylhexyl Phthalate; D000181:Acrylonitrile